CFI rs10033900: What Your Genotype Means
The rs10033900 variant is a common genetic change located near the CFI gene, which plays a critical role in regulating the body's immune response. Research has identified this specific variant as having a statistical association with age-related macular degeneration (AMD) risk.
What each genotype means
Potential lower AMD risk
Research has observed that this genotype is associated with a reduced risk of developing age-related macular degeneration in some European populations. However, evidence is mixed, as other studies have found no significant association or conflicting results in different ethnic groups. It is best understood as a genetic marker with limited, context-dependent evidence rather than a diagnostic indicator.
The C allele is common in European populations, appearing in approximately 50–55% of individuals.
Intermediate risk profile
This heterozygous genotype represents a mixed inheritance of the C and T alleles. Because studies on rs10033900 have produced inconsistent findings—ranging from associations with reduced risk to no association at all—the clinical significance for an individual carrier is unclear. This variant does not have a well-established, singular impact on health or disease progression.
This genotype is common in many populations, carried by a significant portion of individuals in European and some Asian cohorts.
Potential higher AMD risk
In certain studies, the T allele has been identified as the minor allele and has been associated with higher susceptibility to age-related macular degeneration compared to the C allele. However, because scientific literature contains contradictory evidence regarding this variant's role, this association is considered limited and may vary significantly based on your ancestral background. You should not consider this a diagnosis, as its overall impact on individual health remains a subject of ongoing research.
The frequency of this genotype varies by population, typically occurring in roughly 1 in 5 to 1 in 10 individuals depending on the specific ancestry group.
Understanding the rs10033900 Variant
The rs10033900 variant is a single nucleotide polymorphism (SNP) located in the genomic region near the CFI gene on chromosome 4. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. While many SNPs have no observable effect on health, researchers study them to understand how variations in our genetic code might influence susceptibility to complex conditions. The rs10033900 variant is frequently studied in the context of ocular health, specifically regarding how the body manages inflammation and immune system activity in the eye. Because this variant is located in a region associated with the regulation of the complement system, it has become a subject of interest for scientists investigating the underlying genetic architecture of age-related macular degeneration.
The Role of the CFI Gene
The CFI gene provides the instructions for producing a protein called complement factor I. This protein acts as a vital regulator of the complement system, which is a part of the innate immune system that helps the body clear away damaged cells and pathogens. Complement factor I functions as an enzyme that helps turn off the complement cascade, preventing the immune system from becoming overactive and causing unintended damage to healthy tissues. When the complement system is not properly regulated, it can lead to chronic inflammation. In the eye, this persistent, low-level inflammation is thought to contribute to the development of age-related macular degeneration (AMD). By maintaining the balance of the complement pathway, the CFI protein helps protect the delicate structures of the retina from excessive immune-mediated damage.
Research and Evidence Strength
The association between rs10033900 and macular health is supported by observational studies, though the evidence is considered limited in terms of clinical predictability. Research has indicated that the C allele of rs10033900 may be associated with a protective effect against AMD, meaning individuals carrying this allele might show different statistical risks compared to those who do not. However, it is important to note that AMD is a multifactorial condition influenced by a combination of genetics, environmental factors, and lifestyle choices. While genetic studies have identified significant statistical correlations, these findings do not imply a direct cause-and-effect relationship for any single individual. The scientific community continues to investigate how common variants like rs10033900 interact with other rare variants in the CFI gene and broader environmental triggers to influence long-term eye health.
What This Information Means for You
Genetic information regarding variants like rs10033900 is primarily used for research purposes to better understand disease mechanisms. It is not a diagnostic tool and cannot predict whether an individual will develop a specific eye condition. If you are concerned about your vision or have a family history of macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can perform comprehensive eye exams to assess your current ocular health and provide personalized guidance based on your clinical history. You should never use genetic data to make medical decisions or alter your health habits without professional medical advice. Understanding your genetic predispositions can be an interesting part of your health profile, but it should always be viewed alongside clinical evaluations from qualified healthcare providers.
How common is this variant?
The rs10033900 variant is common, with the minor allele frequency observed at approximately 30% in European populations.
Frequently asked questions
Can I use this genetic result to predict if I will get AMD?
No, this genetic variant cannot predict if you will develop age-related macular degeneration. AMD is a complex condition influenced by many genetic and environmental factors, and a single SNP is not a diagnostic test.
What is the complement system?
The complement system is a part of your immune system that helps clear out damaged cells and fight infections. It must be carefully regulated to ensure it does not damage healthy tissues, such as those in the eye.
Should I change my diet based on this result?
You should not change your diet or health habits based on this genetic result. Always consult with a healthcare provider or a registered dietitian before making significant changes to your health regimen.
Where can I find more information about my eye health?
The best source for information about your eye health is a licensed ophthalmologist or optometrist. They can provide exams and advice tailored to your specific medical history.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10033900?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29